logo
Kepler Capital Sticks to Their Buy Rating for Haleon PLC (HLN)

Kepler Capital Sticks to Their Buy Rating for Haleon PLC (HLN)

In a report released on June 26, Karel Zoete from Kepler Capital maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of p440.00. The company's shares closed yesterday at p378.30.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Zoete is an analyst with an average return of -1.8% and a 48.19% success rate. Zoete covers the Consumer Defensive sector, focusing on stocks such as Unilever, Tate & Lyle, and Essity AB.
Haleon PLC has an analyst consensus of Strong Buy, with a price target consensus of p444.83, which is a 17.59% upside from current levels. In a report released on June 20, Berenberg Bank also maintained a Buy rating on the stock with a £5.03 price target.
Based on Haleon PLC's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of p2.78 billion and a net profit of p303 million. In comparison, last year the company earned a revenue of p2.75 billion and had a net profit of p298 million
Based on the recent corporate insider activity of 50 insiders, corporate insider sentiment is neutral on the stock.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Barclays Sticks to Its Buy Rating for Galderma Group AG (GALD)
Barclays Sticks to Its Buy Rating for Galderma Group AG (GALD)

Business Insider

timean hour ago

  • Business Insider

Barclays Sticks to Its Buy Rating for Galderma Group AG (GALD)

Barclays analyst Yihan Li maintained a Buy rating on Galderma Group AG on July 25 and set a price target of CHF140.00. The company's shares closed last Friday at CHF134.50. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Li is ranked #6568 out of 9862 analysts. Galderma Group AG has an analyst consensus of Strong Buy, with a price target consensus of CHF130.52, which is a -2.96% downside from current levels. In a report released on July 25, Citi also maintained a Buy rating on the stock with a CHF140.00 price target. Based on Galderma Group AG's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of CHF1.93 billion and a net profit of CHF160.43 million. In comparison, last year the company earned a revenue of CHF1.84 billion and had a GAAP net loss of CHF54.18 million

Barclays Remains a Buy on Cadence Bank (CADE)
Barclays Remains a Buy on Cadence Bank (CADE)

Business Insider

timean hour ago

  • Business Insider

Barclays Remains a Buy on Cadence Bank (CADE)

In a report released on July 25, Jared Shaw from Barclays maintained a Buy rating on Cadence Bank, with a price target of $43.00. The company's shares closed last Friday at $36.42. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Shaw is a 3-star analyst with an average return of 1.1% and a 53.28% success rate. Shaw covers the Financial sector, focusing on stocks such as UMB Financial, Cadence Bank, and BankUnited. In addition to Barclays, Cadence Bank also received a Buy from Morgan Stanley's Manan Gosalia in a report issued on July 25. However, on July 24, RBC Capital maintained a Hold rating on Cadence Bank (NYSE: CADE). Based on Cadence Bank's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $683.78 million and a net profit of $133.22 million. In comparison, last year the company earned a revenue of $720.9 million and had a net profit of $116.98 million

Barclays Keeps Their Hold Rating on Treatt plc (TET)
Barclays Keeps Their Hold Rating on Treatt plc (TET)

Business Insider

timean hour ago

  • Business Insider

Barclays Keeps Their Hold Rating on Treatt plc (TET)

In a report released on July 25, Setu Sharda from Barclays maintained a Hold rating on Treatt plc, with a price target of £2.20. The company's shares closed last Friday at p206.00. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Sharda is an analyst with an average return of -13.3% and a 26.67% success rate. Sharda covers the Basic Materials sector, focusing on stocks such as AAK AB, Treatt plc, and Corbion NV. In addition to Barclays, Treatt plc also received a Hold from TR | OpenAI – 4o's Dorian Reaxon in a report issued on July 26. However, on July 25, Berenberg Bank maintained a Buy rating on Treatt plc (LSE: TET). TET market cap is currently £121.4M and has a P/E ratio of 11.17.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store